Clinical Trial Update: Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial [Phase 1]

View source ↗

Summary

Phase I dose-escalation study evaluating the safety and feasibility of combining fractionated stereotactic radiosurgery with bevacizumab for brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Neoplasms

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Brain Neoplasm | Phase 1 | Status: UNKNOWN